1891 - 1900 of 8606 Results
Title
Year
- Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathology2024OPENTitle: Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 6Start Page: 4126End Page: 4146Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13828Best OA location URL: https://mouseion.jax.org/stfb2024/161Citation Count: 14
- Die Vermehrung von Alpha‐Synuclein Amyloidfibrillen ist unterdrückt unter vollständig ruhenden Lösungsbedingungen2024RESTRICTEDTitle: Die Vermehrung von Alpha‐Synuclein Amyloidfibrillen ist unterdrückt unter vollständig ruhenden LösungsbedingungenJournal Name: Angewandte ChemiePublisher: WileyVol: 137Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ange.202419173Best OA location URL: https://doi.org/10.1002/ange.202419173Citation Count: 0
- Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study2017OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 80
- Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”2025OPENTitle: Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30272Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30272Citation Count: 0
- Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects against retinal degeneration2022OPENTitle: Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects against retinal degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31869-1Best OA location URL: https://www.nature.com/articles/s41467-022-31869-1.pdfCitation Count: 28
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 0
- Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease2021OPENTitle: Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00260-0Best OA location URL: https://www.nature.com/articles/s41531-021-00260-0.pdfCitation Count: 29
- Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms2018OPENTitle: Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 126End Page: 132Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.004Best OA location URL: https://doi.org/10.1016/j.parkreldis.2018.09.004Citation Count: 43
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease2018OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 143
-
OPENTitle: Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional ActivationJournal Name: Cell ReportsPublisher: Elsevier BVVol: 31Issue #: 13Start Page: 107843End Page: 107843Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2020.107843Best OA location URL: http://www.cell.com/article/S221112472030824X/pdfCitation Count: 334